Johnson & Johnson Share Price BOERSE MUENCHEN

Equities

JNJ

US4781601046

Pharmaceuticals

Market Closed - BOERSE MUENCHEN 20:56:58 13/05/2024 BST 5-day change 1st Jan Change
140.1 EUR +0.70% Intraday chart for Johnson & Johnson +0.30% -1.74%

Financials

Sales 2024 * 88.37B 81.93B 7,038B Sales 2025 * 90.78B 84.17B 7,230B Capitalization 364B 337B 28,986B
Net income 2024 * 22.04B 20.43B 1,755B Net income 2025 * 23.09B 21.41B 1,839B EV / Sales 2024 * 4.04 x
Net cash position 2024 * 7B 6.49B 557B Net cash position 2025 * 21.07B 19.54B 1,679B EV / Sales 2025 * 3.78 x
P/E ratio 2024 *
16.8 x
P/E ratio 2025 *
15.9 x
Employees -
Yield 2024 *
3.19%
Yield 2025 *
3.33%
Free-Float 77.07%
More Fundamentals * Assessed data
Dynamic Chart

Latest transcript on Johnson & Johnson

1 week+1.55%
Current month+3.42%
1 month+1.05%
3 months-4.09%
6 months+1.54%
Current year-1.05%
More quotes
1 week
138.02
Extreme 138.02
140.12
1 month
134.38
Extreme 134.38
142.48
3 years
131.44
Extreme 131.44
178.20
5 years
102.56
Extreme 102.56
178.20
10 years
73.07
Extreme 73.07
178.20
More quotes
Managers TitleAgeSince
Chief Executive Officer 61 31/12/88
Director of Finance/CFO 57 31/12/97
Chief Tech/Sci/R&D Officer 58 04/11/19
Members of the board TitleAgeSince
Director/Board Member 70 24/04/19
Director/Board Member 72 18/06/14
Director/Board Member 70 21/10/09
More insiders
Date Price Change Volume
13/05/24 140.1 +0.70% 1,719
10/05/24 139.1 +0.22% 1,694
09/05/24 138.8 +0.10% 658
08/05/24 138.7 +0.43% 1,434
07/05/24 138.1 +0.09% 1,394

Real-time BOERSE MUENCHEN, May 13, 2024 at 08:56 pm

More quotes
Johnson & Johnson is one of the world's leading producers of healthcare products. Net sales break down by family of products as follows: - pharmaceutical products (55.4%): drugs intended for the treatment of cardiovascular diseases, oncological diseases, gastro-intestinal illnesses, infectious, immunological, neurological, dermatological diseases, etc.; - medical products and equipment (28.9%): diagnostic systems, orthopedic and gynecological equipment, surgical materials, etc. for use by healthcare professionals; - consumer health products (15.7%): OTC drugs (Tylenol, Sudafed, Benadryl, Zyrtec, Motrin, Nicorette and other brands), health and beauty products (Aveeno, Clean & Clear, Dr. CI:Labo, Neutrogena and OGX), baby care products (Johnson's and Aveeno Baby), oral care products (Listerine), feminine hygiene products (Stayfree and Carefree and o.b.), wound care products (Band-Aid and Neosporin) etc. At the end of 2022, Johnson & Johnson has 89 manufacturing facilities located in the United States (28), North America (9), Europe (27), Africa and Asia/Pacific (25). Net sales are distributed geographically as follows: the United States (51.2%), Europe (24.7%), Asia/Pacific and Africa (17.7%) and other (6.4%).
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
22
Last Close Price
151.2 USD
Average target price
173.3 USD
Spread / Average Target
+14.58%
Consensus